Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate

NO_LONGER_AVAILABLE

Conditions studied: Advanced Breast Cancer (Female)

In brief

To provide access to palbociclib to post-menopausal women with HR-positive, HER2-negative advanced breast cancer who are deemed appropriate for letrozole therapy (Canada: first-line patients only).

Key facts

Study ID

NCT02142868

Run by

Pfizer

Last updated by the study team

2018-12-21

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Post-menopausal women 18 years of age or above with proven diagnosis of advanced adenocarcinoma of the breast (locoregionally recurrent or metastatic disease)
• ER-positive and/or PR-positive tumor based on local laboratory results
• HER2-negative tumor based on local laboratory results
• Patients must be appropriate candidates for letrozole therapy (Canada: first-line patients only)

You may not qualify if…

• Patients who have previously participated in a palbociclib trial or who have received prior treatment with any CDK inhibitor

Where it is running

• MedStar Georgetown University Hospital — Washington D.C., District of Columbia, United States
• Washington Cancer Institute at MedStar Washington Hospital Center — Washington D.C., District of Columbia, United States
• Gwinnett Hospital System Inc. -d/b/a - The Center for Cancer Care — Duluth, Georgia, United States
• Gwinnett Hospital System Inc. -d/b/a - The Center for Cancer Care — Lawrenceville, Georgia, United States
• Presence Saint Joseph Hospital — Chicago, Illinois, United States
• North Shore Oncology-Hematology Associates, Ltd. — Crystal Lake, Illinois, United States
• North Shore Oncology-Hematology Associates, Ltd. — Libertyville, Illinois, United States
• Presence Medical Group Hematology Oncology — Northbrook, Illinois, United States
• Illinois CancerCare, P.C. — Peoria, Illinois, United States
• Presence Infusion Care - Skokie — Skokie, Illinois, United States
• Metairie Oncologist, LLC — Metairie, Louisiana, United States
• SKCCC at Johns Hopkins, The Harry and Jeannette Weinberg Building — Baltimore, Maryland, United States
• SKCCC at Johns Hopkins, Green Spring Station — Lutherville, Maryland, United States
• The West Clinic, P.C. — Corinth, Mississippi, United States
• Jackson Oncology Associates, PLLC — Jackson, Mississippi, United States
• Mississippi Baptist Health Systems — Jackson, Mississippi, United States
• Jackson Oncology Associates, PLLC — Jackson, Mississippi, United States
• The West Clinic, P.C. d/b/a West Cancer Center — Southaven, Mississippi, United States
• ProHealthCARE Associates, LLP — Lake Success, New York, United States
• Northwest Cancer Specialists dba Compass Oncology — Portland, Oregon, United States
• Northwest Cancer Specialists dba Compass Oncology — Portland, Oregon, United States
• UPMC Cancer Center Beaver — Beaver, Pennsylvania, United States
• UPMC Cancer Center Arnold Palmer at Mountainview — Greensburg, Pennsylvania, United States
• UPMC Cancer Center Greenville — Greenville, Pennsylvania, United States
• CBCC Global Research, Inc. at Comprehensive Blood & Cancer Center Research Center — Bakersfield, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.